Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-10
2009-12-01
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S262000
Reexamination Certificate
active
07625907
ABSTRACT:
A reactive oxygen generating enzyme inhibitor with NO donor bioactivity, e.g., nitrated allopurinol, is useful to treat heart failure, stable angina, ischemic disorder, ischemic reperfusion injury, atherosclerosis, sickle cell disease, diabetes, Alzheimer's disease, Parkinson's disease, ALS and asthma and to obtain proper contraction of heart, skeletal and smooth muscle.
REFERENCES:
patent: 6359182 (2002-03-01), Stamler et al.
patent: 6538116 (2003-03-01), Stamler et al.
patent: 6887994 (2005-05-01), Stamler et al.
patent: 7067659 (2006-06-01), Stamler et al.
patent: 2003/0171393 (2003-09-01), Soldato
patent: 2003/0176668 (2003-09-01), Stamler et al.
patent: 2004/0006059 (2004-01-01), Stamler et al.
patent: 1336602 (2003-08-01), None
Centers for Disease Control and Prevetion, Chronic Fatigue Syndrome, downloaded Jun. 26, 2009, <http://www.cdc.gov/cfs/cfstreatment.htm>,pp. 1-8.
No Author, “Trilateral Project B3b theme: Comparative study on reach-through claims” [online]. San Francisco, California, Nov. 5-9, 2001, [retrieved on Jun. 26, 2003]. Retrieved from the Internet <http://www.uspto.gov/web/tws/B3b—reachthrough.pdf>.
Beers, M. H., M.D., Editor-In-Chief, the Merck Manual 2ndHome Edition, Chapters 25 and 33, 2005.
Sacks, H., et al., Am. J. Med. , Feb. 1982, 72(2):233-40, Medline Abstract PMID: 7058834.
Norris, S. L., et al., (2005), Ann. Intern. Med., 142: 1112-1119 (Abstract).
Koppel, I. A., et al., J. Am. Chem. Soc., 124(19), 5594-5600 (English) 2002.
Fuchigami, T., et al., Denki Kagaku oyobi Kogyo Butsuri Kagaku, 44(12), 803-8 (Japanese) 1976, Abstract 86:97892 only.
No Author, PDR® entry for Nitrolingual® Pump Spray [online]Tthomson Micromedex 2002-2005 [retrieved Jun. 27, 2006]. Retrieved from Internet <http://www.thomsonhc.com/pdrel/librarian/ND—PR/Pdr/PFPUI/q34KP3RPfNuqK/DDAK/DocumentAppData32025/ND—PG/DocB.
Hare Joshua M.
Stamler Jonathan S.
Toone Eric J.
Bacon & Thomas PLLC
Coleman Brenda L
Duke University
Johns Hopkins University
Moore Susanna
LandOfFree
Reactive oxygen generating enzyme inhibitor with nitric... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reactive oxygen generating enzyme inhibitor with nitric..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reactive oxygen generating enzyme inhibitor with nitric... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4077523